Driven by plummeting numbers of COVID cases across the world post-pandemic, several vaccine manufacturers are dealing with a slump in vaccine demand.
The low level of COVID cases is also encouraging the government to pause coming up with another booster dose. The falling demand for vaccines across western nations like the US, UK, etc, is a major concern for vaccine makers who are sitting over a large inventory of unused COVID vaccines.
Recently, a slump in vaccine demand forced Novavax to request the governments to come up with purchase commitments for their COVID-19 vaccine to help the biotech firm stay afloat amid collapsing demand for jabs, reported Financial Times in its report.
In India, Serum Institute of India announced to restart the manufacturing of Covishield in response to the rising COVID cases.